Arezoo Modiri
Overview
Explore the profile of Arezoo Modiri including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
19
Citations
65
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Modiri A, Mossahebi S, Sawant A, Chen S, Zhang B, Yi B
Phys Med
. 2024 Oct;
127:104829.
PMID: 39368298
Purpose: To explore the feasibility of a novel intensity-modulated proton arc technique that uses a single-energy beam from the cyclotron. The beam energy is externally modulated at each gantry angle...
2.
Vicente E, Grande Gutierrez N, Oakes J, Cammin J, Gopal A, Kipritidis J, et al.
Med Phys
. 2024 May;
51(9):6259-6275.
PMID: 38820385
Background: Investigations on radiation-induced lung injury (RILI) have predominantly focused on local effects, primarily those associated with radiation damage to lung parenchyma. However, recent studies from our group and others...
3.
Yi B, Mossahebi S, Modiri A, Nichols E, Guerrero M, Lamichhane N, et al.
Int J Part Ther
. 2022 Sep;
9(2):31-39.
PMID: 36060416
Purpose: To investigate whether volumetric-modulated proton arc therapy (VPAT) plans generate comparable doses to organs at risk (OARs) compared with interstitial high-dose-rate (iHDR) brachytherapy for patients with gynecologic cancer with...
4.
Waxer J, Wong K, Modiri A, Charpentier A, Moiseenko V, Ronckers C, et al.
Int J Radiat Oncol Biol Phys
. 2022 Sep;
119(2):417-430.
PMID: 36057476
Purpose: Radiation-induced cerebrovascular toxicity is a well-documented sequelae that can be both life-altering and potentially fatal. We performed a meta-analysis of the relevant literature to create practical models for predicting...
5.
Vicente E, Modiri A, Kipritidis J, Yu K, Sun K, Cammin J, et al.
Int J Radiat Oncol Biol Phys
. 2022 Mar;
113(2):456-468.
PMID: 35279324
Purpose: Functional lung avoidance (FLA) radiation therapy (RT) aims to minimize post-RT pulmonary toxicity by preferentially avoiding dose to high-functioning lung (HFL) regions. A common limitation is that FLA approaches...
6.
Modiri A, Vogelius I, Rechner L, Nygard L, Bentzen S, Specht L
Br J Radiol
. 2021 Sep;
94(1127):20210303.
PMID: 34541859
At its core, radiation therapy (RT) requires balancing therapeutic effects against risk of adverse events in cancer survivors. The radiation oncologist weighs numerous disease and patient-level factors when considering the...
7.
Rechner L, Modiri A, Stick L, Maraldo M, Aznar M, Rice S, et al.
Acta Oncol
. 2020 Mar;
59(8):879-887.
PMID: 32216586
In current radiotherapy (RT) planning and delivery, population-based dose-volume constraints are used to limit the risk of toxicity from incidental irradiation of organs at risks (OARs). However, weighing tradeoffs between...
8.
Anvari A, Modiri A, Pandita R, Mahmood J, Sawant A
Med Phys
. 2020 Feb;
47(4):1871-1879.
PMID: 32022928
Purpose: To accomplish novel radiation treatment techniques in preclinical radiation research, small animal image-guided radiotherapy systems have been increasingly integrated into preclinical radiation research over the last decade. Although such...
9.
Vicente E, Modiri A, Yu K, Wibowo H, Yan Y, Timmerman R, et al.
Phys Med Biol
. 2019 Oct;
64(22):225011.
PMID: 31665703
Respiratory motion management techniques in radiotherapy (RT) planning are primarily focused on maintaining tumor target coverage. An inadequately addressed need is accounting for motion in dosimetric estimations in smaller serial...
10.
Stick L, Vogelius I, Modiri A, Rice S, Maraldo M, Sawant A, et al.
Radiother Oncol
. 2019 Apr;
136:9-14.
PMID: 31015135
Background And Purpose: Treatment planning of radiotherapy (RT) for left-sided breast cancer is a challenging case. Several competing concerns are incorporated at present through protocol-defined dose-volume constraints, e.g. cardiac exposure...